Abstract
Many disease conditions considered CNS-predominant harbor significant intestinal comorbidities. Serotonin (5-HT) and the serotonin reuptake transporter (SERT) have increasingly been shown to play important roles in both brain and intestinal development and long-term function. 5-HT and SERT may thus modulate critical functions in the development and perpetuation of brain-gut axis disease. We discuss the potential roles of 5-HT and SERT in the brain and intestinal manifestations of autism spectrum disorders and developmental antidepressant exposure. The potential therapeutic value of 5-HT4 modulation in the subsequent treatment of these conditions is also addressed.
Original language | English (US) |
---|---|
Pages (from-to) | 36-40 |
Number of pages | 5 |
Journal | Journal of chemical neuroanatomy |
Volume | 83-84 |
DOIs | |
State | Published - Oct 2017 |
Keywords
- 5-HT receptor
- Antidepressants
- Autism spectrum disorders
- Brain-gut axis
- Selective serotonin reuptake inhibitors
- Serotonin
- Serotonin reuptake transporter
ASJC Scopus subject areas
- Cellular and Molecular Neuroscience